demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
interferon
IFN beta-1a Darazam ... Kalil ...
IFN beta-1b Darazam ... Rahmani

1 studies excluded by filtering options 0

5402 Davoudi-Monfared, 2020 113high risk of bias